Cargando…

Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a rare cancer with an aggressive disease course. For patients who are medically inoperable or surgically unresectable, multi-agent systemic therapy remains an accepted standard-of-care around the world. Given the rare incidence of MPM and the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotecha, Rupesh, Tonse, Raees, Rubens, Muni, Appel, Haley, Albrecht, Federico, Kaywin, Paul, Alley, Evan W., Tom, Martin C., Mehta, Minesh P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124134/ https://www.ncbi.nlm.nih.gov/pubmed/34063225 http://dx.doi.org/10.3390/cancers13092186

Ejemplares similares

Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data
por: Kutuk, Tugce, et al.
Publicado: (2022)

33. SYSTEMATIC REVIEW AND META-ANALYSIS OF BREAST CANCER BRAIN METASTASIS AND PRIMARY TUMOR RECEPTOR EXPRESSION DISCORDANCE
por: Kotecha, Rupesh, et al.
Publicado: (2020)

Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance
por: Kotecha, Rupesh, et al.
Publicado: (2021)

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
por: Kotecha, Rupesh, et al.
Publicado: (2021)

SPIN-01 RADIATION THERAPY ALONE VERSUS RADIATION THERAPY PLUS RADIOFREQUENCY ABLATION/VERTEBRAL AUGMENTATION FOR SPINE METASTASIS: TRIAL IN PROGRESS
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States
por: Tonse, Raees, et al.
Publicado: (2021)

Hospitalization rates from radiotherapy complications in the United States
por: Tonse, Raees, et al.
Publicado: (2022)

Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer
por: Appunni, Sandeep, et al.
Publicado: (2021)

Hospitalization rates for complications due to systemic therapy in the United States
por: Saxena, Anshul, et al.
Publicado: (2021)

Relationship between insurance status and interhospital transfers among cancer patients in the United States
por: Rubens, Muni, et al.
Publicado: (2022)

RONC-08. SURVIVAL IMPACT OF POSTOPERATIVE RADIOTHERAPY TIMING IN PEDIATRIC AND YOUNG ADULT EPENDYMOMA
por: Shah, Sunny, et al.
Publicado: (2020)

Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: study protocol for a randomized controlled trial
por: Kotecha, Rupesh, et al.
Publicado: (2020)

Burden of maternal and fetal outcomes among pregnant cancer survivors during delivery hospitalizations in the United States
por: Rubens, Muni, et al.
Publicado: (2022)

Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
por: Kutuk, Tugce, et al.
Publicado: (2022)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021)

Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007–2012
por: Appunni, Sandeep, et al.
Publicado: (2021)

New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma
por: Romei, Chiara, et al.
Publicado: (2021)

Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma
por: Lu, Zhenhua, et al.
Publicado: (2022)

Effect of Postoperative Radiation Therapy Timing on Survival in Pediatric and Young Adult Ependymoma
por: Shah, Sunny, et al.
Publicado: (2021)

Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
por: Tsai, Yu-Chen, et al.
Publicado: (2021)

Second Surgery for Recurrent Malignant Pleural Mesothelioma after Multimodality Treatment: A Systematic Review
por: Bellini, Alice, et al.
Publicado: (2022)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of Pleurectomy/Decortication versus Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma
por: Danuzzo, Federica, et al.
Publicado: (2022)

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
por: Hassan, Raffit, et al.
Publicado: (2015)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Chemotherapy for malignant pleural mesothelioma: past results and recent developments
por: Tomek, S, et al.
Publicado: (2003)

Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma
por: Kutuk, Tugce, et al.
Publicado: (2023)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
por: Grosso, Federica, et al.
Publicado: (2018)

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma
por: Karatkevich, Darya, et al.
Publicado: (2022)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f0don3bedo1cld05275evtpflv